PSC
AGN

Prentiss Smith & Co’s Allergan Inc AGN Stock Holding History

Prentiss Smith & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25
Closed -$5K – 342
2014
Q4 		$5K Buy
+25
New +$4.97K ﹤0.01% 278

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Prentiss Smith & Co's AGN Position: Q1 2015 in Review

Prentiss Smith & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 25 shares — an estimated $5K sold.

Prentiss Smith & Co first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $5K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Prentiss Smith & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Prentiss Smith & Co sold 25 Allergan Inc shares in Q1 2015, an estimated $5K.
  • Prentiss Smith & Co first reported a position in Allergan Inc in Q4 2014 and held it in 1 quarter.
  • Prentiss Smith & Co's Allergan Inc position peaked at $5K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Prentiss Smith & Co's 13F filing for Q1 2015, filed 1 May 2015.